David Chen

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

Fabrice André, Ruth O’Regan, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2014 · 489 citations

Advanced Breast Cancer, Breast Oncology, Oncology +8

Human P-Glycoprotein Exhibits Reduced Affinity for Substrates during a Catalytic Transition State

Murali Ramachandra, Suresh V. Ambudkar, David Chen et al. · Biochemistry · 1998 · 253 citations

Optimizing Genetic Circuits by Global Sensitivity Analysis

Xiao‐Jiang Feng, Sara Hooshangi, David Chen et al. · Biophysical Journal · 2004 · 140 citations · Full text

Engineering, Genetics, Computational Biology +7

Inpatient treatment time across disciplines in spinal cord injury rehabilitation

Gale G. Whiteneck, Julie Gassaway, Marcel Dijkers et al. · Journal of Spinal Cord Medicine · 2011 · 95 citations · Full text

A phase 1a clinical trial of LYM‐1 monoclonal antibody serotherapy in patients with refractory b cell malignancies

Eddie Hu, Alan L. Epstein, Gregory S. Naeve et al. · Hematological Oncology · 1989 · 88 citations